2014-003894-41: Effect of Interferon on protecting immune response in chronic hepatitis B patients under treatment for the infection with standard antiviral therapy Effetto dell’Interferone sulla risposta immunitaria proteggente in pazienti con epatite B cronica già in trattamento per l’infezione con terapia antivirale standard |
|
|
| Ongoing | 2 | 80 | Europe | Peginterferone alfa-2a, Entecavir, Tenofovir Disoproxil, Solution for injection in pre-filled syringe, Tablet, Pegasys, Baraclude, Viread | Azienda Ospedaliero-Universitaria di Parma, F. Hoffmann - La Roche Ltd, Gilead Sciences srl, Regione Emilia-Romagna | Chronic hepatitis B infection Infezione da Epatite B cronica, Chronic hepatitis B infection Infezione da Epatite B cronica, Diseases [C] - Virus Diseases [C02] | | | | |
2008-000928-71: TWIST. RANDOMIZED PROSPECTIVE PHASE II STUDY OF TEMSIROLIMUS WITH OR WITHOUT LOW-DOSE INTERFERON ALPHA IN METASTATIC NON-CLEAR RENAL CELL CARCINOMA: GOIRC STUDY 02/2008 |
|
|
| Ongoing | 2 | 68 | Europe | Temsirolimus, CCI-779, ROFERON A, ROFERON A | GRUPPO ONCOLOGICO ITALIANO DI RICERCA | Patients with advanced non-clear Cell Renal Carcinoma. | | | | |
2006-000753-22: A phase I/II feasability trial to assess the safety, immunological activity and efficacy of TroVax plus interferon alpha in patients with advanced or metastatic renal cell cancer. |
|
|
| Ongoing | 1/2 | 10 | Europe | TroVax, Roferon-A, TV, Roferon-A, Roferon-A | Oxford MioMedica UK Ltd. | Advanced or Metastatic Renal Cell Cancer | | | | |
